Vascular Endothelial Growth Factor Receptor-2, antagonists & inhibitors

DBCAT001653Pharmacologic class

A DrugBank category of 3 drugs.

Drugs: Golvatinib
Pegdinetanib
Tesevatinib

What you can answer from here — as of August 24, 2016

3DrugsEach linked to its full drug card

Listed above

6Drug targetsEvery drug–target pair in the class, with bond type

Which targets do Vascular Endothelial Growth Factor Receptor-2, antagonists & inhibitors share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account